Related references
Note: Only part of the references are listed.Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma
Rebecca C. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma
Sandra C. Paek et al.
CANCER (2007)
Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma
Judit Kiss et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Prognostic significance of vascularity in cutaneous melanoma: Pilot study using in vivo confocal scanning laser microscopy
Shannon Humphrey et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2006)
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients
JBAG Haanen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Results of sentinel lymph node biopsy in patients with thin melanoma
SL Wong et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Heterogeneity of T-cell clones infiltrating primary malignant melanomas
Amir S. Yazdi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma
PA Gimotty et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model
VK Sondak et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: Pathologic corollary of eastern cooperative oncology group trial E1690
UNM Rao et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Tumor vascularity in the prognostic assessment of primary cutaneous melanoma
M Kashani-Sabet et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
CM Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
MHC class II-restricted tumor antigens recognized by CD4+ T cells:: New strategies for cancer vaccine design
G Zeng
JOURNAL OF IMMUNOTHERAPY (2001)
High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190
JM Kirkwood et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Incidence of sentinel node metastasis in patients with thin primary melanoma (≤1 mm) with vertical growth phase
I Bedrosian et al.
ANNALS OF SURGICAL ONCOLOGY (2000)
TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas
S Lyle et al.
MODERN PATHOLOGY (2000)
Share Paper
